About the Center

The Center for Biotechnology and Global Health Policy serves as a reference point for research, policy development and advocacy concerning science, biotechnology, bioethics and healthcare in the United States and abroad. The CBGHP engages multiple stakeholder communities: scholars, policy makers, civil society, healthcare providers, the judiciary and the general public, highlighting the collaborative role and function of law in responding to state, federal and international healthcare concerns.
Prof. Goodwin headshot
Michele Bratcher Goodwin is a Chancellor’s Professor at the University of California, Irvine and founding director of the Center for Biotechnology and Global Health Policy. She is the recipient of the 2020-21 Distinguished Senior Faculty Award for Research, the highest honor bestowed by the University of California. She is also the first law professor at the University of California, Irvine to receive this award. She is an elected member of the American Law Institute as well as an elected Fellow of the American Bar Foundation and the Hastings Center (the organization central to the founding of bioethics). She is an American Law Institute Adviser for the Restatement Third of Torts: Remedies. More about Prof. Goodwin > | VIDEO: About the Center for Biotechnology and Global Health Policy >

Mission: To educate the public and serve as a catalyst for the advancement of society through research, educational outreach and advocacy.

Activities

The Center for Biotechnology and Global Health Policy prioritizes collaborative, cross-cultural and interdisciplinary exchanges, bringing scholars, policy makers, nongovernmental organization members and others to the University of California, Irvine for roundtables, symposia and points of engagement. More about CBGHP Activities >

Initiatives

The Center engages three major initiatives: Public Health and Legal Policy; Reproductive Justice; and Biotechnology and National Security. More about CBGHP Initiatives >